The ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma

SpringerPlus

Volumn 3, Issue 1, 2014, Pages

  van Roosmalen, Ingrid A M ^a,b   Reis, Carlos R ^a,c   Setroikromo, Rita ^a   Yuvaraj, Saravanan ^b,d   Joseph, Justin V ^b   Tepper, Pieter G ^a   Kruyt, Frank A E ^b   Quax, Wim J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

2,5 dimethyl celecoxib (DMC); Apoptosis; Endoplasmic reticulum (ER) stress; Glioblastoma multiforme (GBM); TNF related apoptosis inducing ligand (TRAIL)

Indexed keywords

EID: 84931265311     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-3-495     Document Type: Article

References (46)

1. Ahlstrom MM, Ridderstrom M, Zamora I, Luthman K: CYP2C9 structure-metabolism relationships: optimizing the metabolic stability of COX-2 inhibitors.J Med Chem 2007,50(18):4444–4452. 10.1021/jm0705096
2. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH: Safety and antitumor activity of recombinant soluble Apo2 ligand.J Clin Invest 1999,104(2):155–162. 10.1172/JCI6926
3. Boyce M, Yuan J: Cellular response to endoplasmic reticulum stress: a matter of life or death.Cell Death Differ 2006,13(3):363–373. 10.1038/sj.cdd.4401817
4. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X: Biochemical pathways of caspase activation during apoptosis.Annu Rev Cell Dev Biol 1999, 15: 269–290. 10.1146/annurev.cellbio.15.1.269
5. Capper D, Gaiser T, Hartmann C, Habel A, Mueller W, Herold-Mende C, von Deimling A, Siegelin MD: Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation.Acta Neuropathol 2009,117(4):445–456. 10.1007/s00401-009-0494-3
6. Chen L, Smith L, Wang Z, Smith JB: Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination.Mol Pharmacol 2003,64(2):334–345. 10.1124/mol.64.2.334
7. Chen S, Liu X, Yue P, Schonthal AH, Khuri FR, Sun SY: CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.Mol Pharmacol 2007,72(5):1269–1279. 10.1124/mol.107.037465
8. Chuang HC, Kardosh A, Gaffney KJ, Petasis NA, Schonthal AH: COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro.Mol Cancer 2008, 7: 38.
9. Ehrhardt H, Wachter F, Grunert M, Jeremias I: Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis.Cell Death Dis 2013, 4: e661. 10.1038/cddis.2013.179
10. Fulda S, Meyer E, Debatin KM: Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.Oncogene 2002,21(15):2283–2294. 10.1038/sj.onc.1205258
11. Gaiser T, Becker MR, Habel A, Reuss DE, Ehemann V, Rami A, Siegelin MD: TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin.Neurosci Lett 2008,442(2):109–113. 10.1016/j.neulet.2008.07.014
12. Gorman AM, Healy SJ, Jager R, Samali A: Stress management at the ER: regulators of ER stress-induced apoptosis.Pharmacol Ther 2012,134(3):306–316. 10.1016/j.pharmthera.2012.02.003
13. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, Manabe T, Yamagishi S, Bando Y, Imaizumi K, Tsujimoto Y, Tohyama M: Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death.J Cell Biol 2004,165(3):347–356. 10.1083/jcb.200310015
14. Johnson AJ, Hsu AL, Lin HP, Song X, Chen CS: The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks.Biochem J 2002,366(Pt 3):831–837.
15. Kardosh A, Golden EB, Pyrko P, Uddin J, Hofman FM, Chen TC, Louie SG, Petasis NA, Schonthal AH: Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.Cancer Res 2008,68(3):843–851. 10.1158/0008-5472.CAN-07-5555
16. Kardosh A, Wang W, Uddin J, Petasis NA, Hofman FM, Chen TC, Schonthal AH: Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt’s lymphoma in vitro and in vivo.Cancer Biol Ther 2005,4(5):571–582. 10.4161/cbt.4.5.1699
17. Kim IY, Kang YJ, Yoon MJ, Kim EH, Kim SU, Kwon TK, Kim IA, Choi KS: Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation.Neuro Oncol 2011,13(3):267–279. 10.1093/neuonc/noq195
18. Kim R, Emi M, Tanabe K, Murakami S: Role of the unfolded protein response in cell death.Apoptosis 2006,11(1):5–13. 10.1007/s10495-005-3088-0
19. Knight MJ, Riffkin CD, Muscat AM, Ashley DM, Hawkins CJ: Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells.Oncogene 2001,20(41):5789–5798. 10.1038/sj.onc.1204810
20. Kouri FM, Jensen SA, Stegh AH: The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond.ScientificWorldJournal 2012, 2012: 838916.
21. Kuijlen JM, Mooij JJ, Platteel I, Hoving EW, van der Graaf WT, Span MM, Hollema H, den Dunnen WF: TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.J Neurooncol 2006,78(2):161–171. 10.1007/s11060-005-9081-1
22. Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S, Pai R, Leung S, Khan L, Gliniak B, Bussiere J, Smith CA, Strom SS, Kelley S, Fox JA, Thomas D, Ashkenazi A: Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions.Nat Med 2001,7(4):383–385. 10.1038/86397
23. Lee AS: The glucose-regulated proteins: stress induction and clinical applications.Trends Biochem Sci 2001,26(8):504–510. 10.1016/S0968-0004(01)01908-9
24. Lee SY, Lee MS, Cherla RP, Tesh VL: Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells.Cell Microbiol 2008,10(3):770–780. 10.1111/j.1462-5822.2007.01083.x
25. Li J, Lee AS: Stress induction of GRP78/BiP and its role in cancer.Curr Mol Med 2006,6(1):45–54. 10.2174/156652406775574523
26. Martin-Perez R, Niwa M, Lopez-Rivas A: ER stress sensitizes cells to TRAIL through down-regulation of FLIP and Mcl-1 and PERK-dependent up-regulation of TRAIL-R2.Apoptosis 2012,17(4):349–363. 10.1007/s10495-011-0673-2
27. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ: Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state.Mol Cell Biol 2001,21(4):1249–1259. 10.1128/MCB.21.4.1249-1259.2001
28. Mica L, Harter L, Trentz O, Keel M: Endotoxin reduces CD95-induced neutrophil apoptosis by cIAP-2-mediated caspase-3 degradation.J Am Coll Surg 2004,199(4):595–602. 10.1016/j.jamcollsurg.2004.05.272
29. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.J Biol Chem 1996,271(22):12687–12690. 10.1074/jbc.271.22.12687
30. Pyrko P, Kardosh A, Liu YT, Soriano N, Xiong W, Chow RH, Uddin J, Petasis NA, Mircheff AK, Farley RA, Louie SG, Chen TC, Schonthal AH: Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.Mol Cancer Ther 2007,6(4):1262–1275. 10.1158/1535-7163.MCT-06-0629
31. Pyrko P, Soriano N, Kardosh A, Liu YT, Uddin J, Petasis NA, Hofman FM, Chen CS, Chen TC, Schonthal AH: Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.Mol Cancer 2006, 5: 19. 10.1186/1476-4598-5-19
32. Qi L, Bellail AC, Rossi MR, Zhang Z, Pang H, Hunter S, Cohen C, Moreno CS, Olson JJ, Li S, Hao C: Heterogeneity of primary glioblastoma cells in the expression of caspase-8 and the response to TRAIL-induced apoptosis.Apoptosis 2011,16(11):1150–1164. 10.1007/s10495-011-0645-6
33. Reis CR, van der Sloot AM, Natoni A, Szegezdi E, Setroikromo R, Meijer M, Sjollema K, Stricher F, Cool RH, Samali A, Serrano L, Quax WJ: Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants.Cell Death Dis 2010, 1: e83. 10.1038/cddis.2010.61
34. Siegelin MD: Utilization of the cellular stress response to sensitize cancer cells to TRAIL-mediated apoptosis.Expert Opin Ther Targets 2012,16(8):801–817. 10.1517/14728222.2012.703655
35. Song JH, Song DK, Pyrzynska B, Petruk KC, Van Meir EG, Hao C: TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways.Brain Pathol 2003,13(4):539–553.
36. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups & National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N Engl J Med 2005,352(10):987–996. 10.1056/NEJMoa043330
37. Suzuki Y, Nakabayashi Y, Takahashi R: Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death.Proc Natl Acad Sci U S A 2001,98(15):8662–8667. 10.1073/pnas.161506698
38. Tan M, Gallegos JR, Gu Q, Huang Y, Li J, Jin Y, Lu H, Sun Y: SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection.Neoplasia 2006,8(12):1042–1054. 10.1593/neo.06568
39. Tanaka K, Tomisato W, Hoshino T, Ishihara T, Namba T, Aburaya M, Katsu T, Suzuki K, Tsutsumi S, Mizushima T: Involvement of intracellular Ca2+ levels in nonsteroidal anti-inflammatory drug-induced apoptosis.J Biol Chem 2005,280(35):31059–31067. 10.1074/jbc.M502956200
40. Tian X, Ye J, Alonso-Basanta M, Hahn SM, Koumenis C, Dorsey JF: Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).J Biol Chem 2011,286(33):29408–29416. 10.1074/jbc.M110.197665
41. van der Sloot AM, Tur V, Szegezdi E, Mullally MM, Cool RH, Samali A, Serrano L, Quax WJ: Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor.Proc Natl Acad Sci U S A 2006,103(23):8634–8639. 10.1073/pnas.0510187103
42. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA: Identification and characterization of a new member of the TNF family that induces apoptosis.Immunity 1995,3(6):673–682. 10.1016/1074-7613(95)90057-8
43. Wu J, Kaufman RJ: From acute ER stress to physiological roles of the unfolded protein response.Cell Death Differ 2006,13(3):374–384. 10.1038/sj.cdd.4401840
44. Xie D, Zeng YX, Wang HJ, Wen JM, Tao Y, Sham JS, Guan XY: Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma.Br J Cancer 2006,94(1):108–114. 10.1038/sj.bjc.6602904
45. Yoon MJ, Kang YJ, Kim IY, Kim EH, Lee JA, Lim JH, Kwon TK, Choi KS: Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation.Carcinogenesis 2013,34(8):1918–1928. 10.1093/carcin/bgt137
46. Zhou Y, Tian L, Long L, Quan M, Liu F, Cao J: Casticin potentiates TRAIL-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress.PLoS One 2013,8(3):e58855. 10.1371/journal.pone.0058855